An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer

The clinical potency of anti-programmed death-ligand 1 (PD-L1) therapy in metastatic triple-negative breast cancer (TNBC) is modest primarily because of the intrinsic low immunogenicity and an immunosuppressive tumor microenvironment (TME). Photodynamic therapy (PDT), an inducer of immunogenic cell...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Yuetong Liu, Liming Wang, Feiyan Kong, Tianjun Liu, Hong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Subjects:	photodynamic therapy immunogenic cell death metastatic triple-negative breast cancer programmed death-ligand 1 blockade abscopal effect systemic antitumor immunity
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1651165/full

Similar Items

Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
by: Wei Xie, et al.
Published: (2019-11-01)

An Albumin‐Photosensitizer Supramolecular Assembly with Type I ROS‐Induced Multifaceted Tumor Cell Deaths for Photodynamic Immunotherapy
by: Jingtian Zhang, et al.
Published: (2025-03-01)

Bibliometric analysis of photodynamic therapy and immune response from 1989–2023
by: Wanting Fan, et al.
Published: (2024-01-01)

Antitumor Immune Response Triggered by Metal-Based Photosensitizers for Photodynamic Therapy: Where Are We?
by: Alain C. Jung, et al.
Published: (2021-10-01)

Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
by: Yang Hao, et al.
Published: (2022-08-01)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
by: Yujie Zhao, et al.
Published: (2022-09-01)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
by: Yuetong Liu, et al.
Published: (2023-04-01)

Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis
by: Zhu H, et al.
Published: (2023-06-01)

Corrigendum: Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works
by: Wangcai Ren, et al.
Published: (2025-01-01)

Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works
by: Wangcai Ren, et al.
Published: (2025-01-01)

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
by: Yuhang Fang, et al.
Published: (2022-10-01)

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
by: Zong Sheng Guo, et al.
Published: (2017-05-01)

Polymer-assisted PD-L1 degradation and targeted photodynamic therapy synergize to suppress immunodeficient tumors
by: Changyong Guo, et al.
Published: (2025-07-01)

Pheophorbide A–Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD–L1 Expression
by: Qinli Tong, et al.
Published: (2022-11-01)

Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
by: Bastien Doix, et al.
Published: (2019-08-01)

Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies
by: Timothy M. Fan, et al.
Published: (2019-01-01)

Activation of pyroptosis by specific organelle-targeting photodynamic therapy to amplify immunogenic cell death for anti-tumor immunotherapy
by: Shuang Zeng, et al.
Published: (2023-07-01)

Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis
by: Xiaoqin Zheng, et al.
Published: (2023-12-01)

Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
by: Tao Xu, et al.
Published: (2025-04-01)

Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy
by: Luciana Dini, et al.
Published: (2012-08-01)

Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade
by: Seong Dong Jeong, et al.
Published: (2021-04-01)

IR813-Induced Photothermal Therapy: Leveraging Immunogenic Cell Death for Cancer Treatment
by: Guangwei Jiang, et al.
Published: (2025-01-01)

Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer
by: Xiaobo Wang, et al.
Published: (2023-09-01)

Self-delivery immunological adenosine effector for photodynamic activated immunotherapy against metastatic tumors
by: Xiayun Chen, et al.
Published: (2023-11-01)

Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer
by: Yu Liu, et al.
Published: (2025-03-01)

Galactose-modified zinc phthalocyanines for colon cancer photodynamic therapy
by: Weiying Ge, et al.
Published: (2025-10-01)

Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
by: Huancheng Zeng, et al.
Published: (2024-10-01)

Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor
by: Xinlun Dai, et al.
Published: (2023-12-01)

Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
by: Zhian Chen, et al.
Published: (2025-04-01)

Cell death shapes cancer immunity: spotlighting PANoptosis
by: Lixia Gao, et al.
Published: (2024-06-01)

Advancements in Nano-Delivery Systems for Photodynamic and Photothermal Therapy to Induce Immunogenic Cell Death in Tumor Immunotherapy
by: Zhao R, et al.
Published: (2025-06-01)

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
by: Jeongrae Kim, et al.
Published: (2022-02-01)

Tumor lysis with LTX-401 creates anticancer immunity
by: Wei Xie, et al.
Published: (2019-07-01)

Enhancing the efficacy of immunotherapy using radiotherapy
by: Synat Keam, et al.
Published: (2020-01-01)

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
by: Yujeong Moon, et al.
Published: (2024-06-01)

Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer
by: Yanhong Duo, et al.
Published: (2023-12-01)

Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
by: Hiroyuki Araki, et al.
Published: (2022-12-01)

Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy
by: Haiqin Song, et al.
Published: (2022-07-01)

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
by: Baoyuan Zhang, et al.
Published: (2024-02-01)

Turning foes to friends: Advanced “in situ nanovaccine” with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer
by: Ze Wang, et al.
Published: (2024-09-01)